title: Cyclooxygenase-2 gene disruption promotes proliferation of murine calvarial osteoblasts in vitro.
abstract: Cyclooxygenase-2 (COX-2) is highly expressed in osteoblasts, and COX-2 produced prostaglandins (PGs) can increase osteoblastic differentiation in vitro. The goal of this study was to examine effects of COX-2 expression on calvarial osteoblastic proliferation and apoptosis. Primary osteoblasts (POBs) were cultured from calvariae of COX-2 wild-type (WT) and knockout (KO) mice. POB proliferation was evaluated by (3)H-thymidine incorporation and analysis of cell replication and cell cycle distribution by flow cytometry. POB apoptosis was evaluated by annexin and PI staining on flow cytometry. As expected, PGE(2) production and alkaline phosphatase (ALP) activity were increased in WT cultures compared to KO cultures. In contrast, cell numbers were decreased in WT compared to KO cells by day 4 of culture. Proliferation, measured on days 3-7 of culture, was 2-fold greater in KO than in WT POBs and associated with decreased Go/G1 and increased S cell cycle distribution. There was no significant effect of COX-2 genotype on apoptosis under basal culture conditions on day 5 of culture. Cell growth was decreased in KO POBs by the addition of PGE(2) or a protein kinase A agonist and increased in WT POBs by the addition of NS398, a selective COX-2 inhibitor. In contrast, differentiation and cell growth in marrow stromal cell (MSC) cultures, evaluated by ALP and crystal violet staining respectively, were increased in MSCs from WT mice compared to MSCs from KO mice, and exogenous PGE(2) increased cell growth in KO MSC cultures. We conclude that PGs secondary to COX-2 expression decrease osteoblastic proliferation in cultured calvarial cells but increase growth of osteoblastic precursors in MSC cultures.
authors.affiliation: Department of Medicine, Room N4051, MARB, MC5456, University of Connecticut Health Center, Farmington, 263 Farmington Avenue, Farmington, CT 06030, USA.
authors.forename: Zheng
authors.initials: Z
authors.lastname: Xu
authors.forename: Shilpa
authors.initials: S
authors.lastname: Choudhary
authors.forename: Yosuke
authors.initials: Y
authors.lastname: Okada
authors.forename: Olga
authors.initials: O
authors.lastname: Voznesensky
authors.forename: Cynthia
authors.initials: C
authors.lastname: Alander
authors.forename: Lawrence
authors.initials: L
authors.lastname: Raisz
authors.forename: Carol
authors.initials: C
authors.lastname: Pilbeam
mesh_terms: D000469:Alkaline Phosphatase / Q000378:metabolism; D000818:Animals; D017209:Apoptosis; D001854:Bone Marrow Cells / Q000166:cytology / Q000378:metabolism; D049109:Cell Proliferation; D002478:Cells, Cultured; D051546:Cyclooxygenase 2 / Q000172:deficiency* / Q000235:genetics*; D015232:Dinoprostone / Q000096:biosynthesis / Q000494:pharmacology; D066298:In Vitro Techniques; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D010006:Osteoblasts / Q000166:cytology* / Q000187:drug effects / Q000201:enzymology*; D012886:Skull / Q000166:cytology; D017154:Stromal Cells / Q000166:cytology / Q000378:metabolism
chemical_list: C077623:Ptgs2 protein, mouse; D051546:Cyclooxygenase 2; D000469:Alkaline Phosphatase; D015232:Dinoprostone